Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04417465
Title First In Human Study With ABBV-CLS-579 When Given Alone Or In Combination With Programmed Cell Death-1 Inhibitor In Participants With Locally Advanced Or Metastatic Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Calico Life Sciences LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | FRA | ESP

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Springdale Arkansas 72762 United States Details
Yale University New Haven Connecticut 06519 United States Details
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Hopital Saint-Andre Bordeaux 33000 France Details
Institut Gustave Roussy Villejuif 94805 France Details
The Chaim Sheba Medical Center Ramat Gan 5262100 Israel Details
National Cancer Center Hospital East Kashiwa-Shi Chiba 277-8577 Japan Details
Wakayama Medical University Hospital Wakayama-Shi Wakayama 641-8510 Japan Details
National Cancer Center Hospital Chuo-ku, Tokyo 104-0045 Japan Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
National Taiwan University Hospital Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field